IS2649B - 1,2,4-triaminobenzene derivatives useful for treating central nervous system disorders - Google Patents

1,2,4-triaminobenzene derivatives useful for treating central nervous system disorders

Info

Publication number
IS2649B
IS2649B IS7856A IS7856A IS2649B IS 2649 B IS2649 B IS 2649B IS 7856 A IS7856 A IS 7856A IS 7856 A IS7856 A IS 7856A IS 2649 B IS2649 B IS 2649B
Authority
IS
Iceland
Prior art keywords
nervous system
central nervous
system disorders
derivatives useful
treating central
Prior art date
Application number
IS7856A
Other languages
Icelandic (is)
Other versions
IS7856A (en
Inventor
Mario Rottlander
Andreas Ritzen
Morten Norgaard Bang
Nikolay Khanzhin
Christian Tornoe Wenzel
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35295526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS2649(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/DK2003/000906 external-priority patent/WO2004058739A1/en
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of IS7856A publication Critical patent/IS7856A/en
Publication of IS2649B publication Critical patent/IS2649B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS7856A 2002-12-27 2005-05-23 1,2,4-triaminobenzene derivatives useful for treating central nervous system disorders IS2649B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200202012 2002-12-27
PCT/DK2003/000906 WO2004058739A1 (en) 2002-12-27 2003-12-18 1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system

Publications (2)

Publication Number Publication Date
IS7856A IS7856A (en) 2005-05-23
IS2649B true IS2649B (en) 2010-08-15

Family

ID=35295526

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7856A IS2649B (en) 2002-12-27 2005-05-23 1,2,4-triaminobenzene derivatives useful for treating central nervous system disorders

Country Status (16)

Country Link
KR (1) KR20050089862A (en)
CN (1) CN100448867C (en)
AR (1) AR042656A1 (en)
BR (1) BR0317748A (en)
CL (1) CL2003002748A1 (en)
EA (1) EA008589B1 (en)
IS (1) IS2649B (en)
MY (1) MY139844A (en)
NO (1) NO20053612L (en)
PE (1) PE20041015A1 (en)
PL (1) PL377221A1 (en)
SI (1) SI1578740T1 (en)
TW (1) TWI325414B (en)
UA (1) UA79666C2 (en)
UY (1) UY28151A1 (en)
ZA (1) ZA200504565B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200259A1 (en) * 1992-01-08 1993-07-15 Asta Medica Ag NEW 1,2,4-TRIAMINOBENZOL DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
DE19539861A1 (en) * 1995-10-26 1997-04-30 Asta Medica Ag Use of 4-amino-4- (4-fluorobenzylamino) -1-ethoxy-carbonylaminobenzen for the prophylaxis and treatment of the consequences of acute and chronic cerebral low blood circulation and neurodegenerative diseases
GB9915414D0 (en) * 1999-07-01 1999-09-01 Glaxo Group Ltd Medical use
US6117900A (en) * 1999-09-27 2000-09-12 Asta Medica Aktiengesellschaft Use of retigabine for the treatment of neuropathic pain
US6589986B2 (en) * 2000-12-20 2003-07-08 Wyeth Methods of treating anxiety disorders

Also Published As

Publication number Publication date
SI1578740T1 (en) 2007-08-31
NO20053612D0 (en) 2005-07-25
PE20041015A1 (en) 2005-01-08
UA79666C2 (en) 2007-07-10
NO20053612L (en) 2005-09-23
CN1732162A (en) 2006-02-08
EA200501053A1 (en) 2005-12-29
ZA200504565B (en) 2006-08-30
CL2003002748A1 (en) 2005-04-08
PL377221A1 (en) 2006-01-23
UY28151A1 (en) 2004-07-30
CN100448867C (en) 2009-01-07
TWI325414B (en) 2010-06-01
IS7856A (en) 2005-05-23
KR20050089862A (en) 2005-09-08
EA008589B1 (en) 2007-06-29
BR0317748A (en) 2005-11-22
MY139844A (en) 2009-11-30
HK1088317A1 (en) 2006-11-03
AR042656A1 (en) 2005-06-29
TW200413280A (en) 2004-08-01

Similar Documents

Publication Publication Date Title
IS6003A (en) Monoamine reuptake inhibitors for the treatment of central nervous system disorders
LTPA2019521I1 (en) Rapamycin derivative for the treatment of solid tumors associated with unregulated angiogenesis
DK1474416T3 (en) Dihydrobenzodiazepine-2-one derivatives for the treatment of neurological disorders
AU2003249983A8 (en) Piperidines useful for the treatment of central nervous system disorders
PL373626A1 (en) Treatment for central nervous system disorders
DE60216115D1 (en) BENZIMIDAZO 4,5-föISOCHINOLINONE DERIVATIVES
IS7941A (en) Benzazepine derivatives for the treatment of neurological disorders
ID30276A (en) METHODS FOR TREATING SEXUAL DISORDERS
NO20034930L (en) Substituted cyclohexane-1,4-diamine derivatives
DE60214428D1 (en) 1, 4-DIHYDRO-1, 4-DIPHENYLPYRIDINE DERIVATIVES
IL176581A0 (en) Immunomodulatory compounds for the treatment of central nervous system disorders
DK1578740T3 (en) 1,2,4-triaminobenzene derivatives suitable for the treatment of central nervous system disorders
DK1339406T3 (en) Piperazine derivatives, processes for their preparation and use thereof for the treatment of central nervous system disorders
NO20041386L (en) Combinations for the treatment of immuno-inflammatory disorders
NO20033821D0 (en) Use of GABA A inverse agonists in combination with nicotine receptor delagonists, estrogen, selective estrogen modulators, or vitamin E for the treatment of cognitive disorders
ATE452892T1 (en) SUBSTITUTED 8-PERFLUORO-6,7,8,9-TETRAHYDROPYRIMIDO-(1,2A) PYRIMIDIN-4-ONE DERIVATIVES
AU2003250475A8 (en) 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors
DE69923189D1 (en) Device for tensioning risers
MXPA03006607A (en) Combined method for treating hormono-dependent disorders.
IS7288A (en) Methods for purifying levofloxacin
IL166226A0 (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2A receptor-related disorders
IS2172B (en) Indole derivatives useful for the treatment of nervous system disorders
EP1565448A4 (en) PROCESS FOR THE PREPARATION OF 10H-DIBENZO B, F 1,4 THIAZEPIN-11-ONE
IS2649B (en) 1,2,4-triaminobenzene derivatives useful for treating central nervous system disorders
DK1468686T3 (en) S-methyl-dihydro-ziprasidone for the treatment of psychiatric disorders